Many recent studies have demonstrated that AD is a degenerative metabolic disease characterized by a defective glucose utilization, brain insulin responsiveness, and energy metabolism, which are risks factors to oxidative stress and neuroinflammation [197,198,199]. This evidence concerns the gene INS and Other metabolic disease.